tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Heather Behanna, 10 are a HOLD (38.46%), 16 are a BUY (61.54%).
Analyst Heather Behanna, carries an average stock price target met ratio of 92.86% that have a potential upside of 73.97% achieved within 276 days. Previously, Heather Behanna worked at WEDBUSH.
Heather Behanna’s has documented 51 price targets and ratings displayed on 7 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on ALXN, Alexion Pharmaceuticals at 11-Dec-2016.
Analyst best performing recommendations are on SRPT (SAREPTA THERAPEUTICS).
The best stock recommendation documented was for SRPT (SAREPTA THERAPEUTICS) at 5/20/2015. The price target of $25 was fulfilled within 1 day with a profit of $1.24 (4.73%) receiving and performance score of 47.26.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$50
$27.19 (119.20%)
$50
1 months 9 days ago
(21-Sep-2025)
0/10 (0%)
$31.35 (168.10%)
Buy
$22
$-0.81 (-3.55%)
$98
1 months 16 days ago
(14-Sep-2025)
16/25 (64%)
$4.53 (25.93%)
229
Hold
$15
$-7.81 (-34.24%)
$160
1 months 22 days ago
(08-Sep-2025)
15/20 (75%)
$-2.64 (-14.97%)
133
Sell
$5
$-17.81 (-78.08%)
$40
2 months 6 days ago
(24-Aug-2025)
8/11 (72.73%)
$-13.06 (-72.31%)
55
Sell
$16
$-6.81 (-29.86%)
$10
2 months 10 days ago
(20-Aug-2025)
4/16 (25%)
$-4.06 (-20.24%)
246
What Year was the first public recommendation made by Heather Behanna?
